Neutralizing antibodies are considered a correlate of protection against SARS-CoV-2
infection and severe COVID-19, although they are not the only contributing factor to …

The emergence of COVID-19 in 2019 has resulted in a significant global health crisis.
Consequently, extensive research was published to understand and mitigate the disease. In …

Background: Vaccine-induced SARS-CoV-2-anti-spike antibody (anti-S/RBD) titers are often
used as a marker of immune protection and to anticipate the risk of breakthrough infections …

This study characterizes antibody and T-cell immune responses over time until the booster
dose of COronaVIrus Disease 2019 (COVID-19) vaccines in patients with multiple sclerosis …

Using a quartz crystal microbalance with dissipation monitoring (QCM-D), the complex high-
frequency viscosity,= η′− iη′′, of concentrated solutions of a monoclonal antibody (mAb) …

A previously unknown coronavirus, named Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), emerged in the city of Wuhan, China, in December 2019. Its …

Immunocompromised (IC) patients are at higher risk for persistent and/or severe SARS-CoV-
2 infection caused by different viral variants, with a high casefatality ratio. 1, 2 The first …

We highlighted in this current paper similar prolonged respiratory presentation with COVID-
19 pneumonia in four severely immunocompromised patients currently being treated with …

In the last 20 years, zoonotic diseases have been responsible for important outbreaks such
as Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome …

Abstract SARS-CoV-2 infection, which can lead to severe disease known as COVID-19,
differs in children compared with adults. The differences are not only in the clinical …